Gut Barrier Permeability-α-Synuclein Axis Modulation

Mechanistic description

Dysbiotic bacteria compromise intestinal barrier integrity through zonulin pathway activation, allowing bacterial antigens and α-synuclein oligomers to enter systemic circulation and seed CNS pathology. Targeted tight junction stabilizers could prevent this peripheral-to-central disease propagation.

Mechanism / pathway

CLDN1, OCLN, ZO1, MLCK
→
Gut-brain axis / microbiome signaling
→
neurodegeneration

Evidence for (5)

Macrophage-derived CTSS drives the age-dependent disruption of the blood-CSF barrier.

PMID:40015275 2025 Neuron
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.

PMID:37924938 2023 Cancer Lett
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.

PMID:36542691 2022 Sci Transl Med
Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin).

PMID:38497494 2024 Autophagy
Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.

PMID:37734479 2024 J Invest Dermatol

Evidence against (2)

The microbiome-gut-brain axis in Parkinson disease remains difficult to translate from mechanistic models to causal human intervention evidence.

PMID:35750883 2022 Nat Rev Neurol
Microbiome-based Parkinson therapies are still experimental with unresolved strain selection, endpoint, and clinical efficacy questions.

PMID:39568727 2024 Front Nutr

Evidence matrix

5 supporting 2 contradicting

53% posterior support

Supporting

Macrophage-derived CTSS drives the age-dependent disruption of the blood-CSF barrier. PMID:40015275 · 2025 · Neuron
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer. PMID:37924938 · 2023 · Cancer Lett
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity. PMID:36542691 · 2022 · Sci Transl Med
Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin). PMID:38497494 · 2024 · Autophagy
Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes. PMID:37734479 · 2024 · J Invest Dermatol

Contradicting

The microbiome-gut-brain axis in Parkinson disease remains difficult to translate from mechanistic models to causal human intervention evidence. PMID:35750883 · 2022 · Nat Rev Neurol
Microbiome-based Parkinson therapies are still experimental with unresolved strain selection, endpoint, and clinical efficacy questions. PMID:39568727 · 2024 · Front Nutr

Top-ranked evidence

trust_score × relevance_score × exp(-recency_weight × recency_days / 365)

Supports · top 3

#1 paper-c7f9efeb3094 0.466 trust 0.50 · rel 1.00 · 85d
#2 paper-254ec7d567f1 0.466 trust 0.50 · rel 1.00 · 85d
#3 paper-cd47ad073544 0.466 trust 0.50 · rel 1.00 · 85d

59 total ranked · scidex.hypotheses.evidence_ranking

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). Gut Barrier Permeability-α-Synuclein Axis Modulation. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-6c83282d

BibTeX

@misc{scidex_hypothesis_h6c83282,
  title        = {Gut Barrier Permeability-α-Synuclein Axis Modulation},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-6c83282d},
  note         = {SciDEX artifact hypothesis:h-6c83282d}
}